Cannabis Market
The cannabis industry is experiencing unprecedented growth globally, this progress in a political level responds essentially to the growing social demand for regulation of the use of medicinal cannabis.
The cannabis plant contains chemical substances that can be useful to treat a wide range of diseases and symptoms.
More and more countries are legalizing marihuana for medicinal use.
Scientists are making clinical and preclinical trials with cannabis and its extracts to treat the symptoms of diseases and other disorders, such as:
- HIV/AIDS
- Multiple sclerosis (MS)
- Inflammation
- Pain seizures
- Drug use disorders
- Mental disorders
The scientific study of chemicals, called cannabinoids, has led to the FDA approval of two cannabinoid containing pills.
Mexico: The Next Significant Market to Come Online
- Largest country on the path to legalization
- Established export infrastructure
- Developed pharma industry low cost market
- Legal and/or legislation in progress
- International sales opportunity
Poised to Dominate Mexico’s Cannabis Market. We are on the inside track with a first mover advantage to tap into a massive market opportunity with significant barriers to entry
20+ years legacy pharma business prepared to launch and take market share in Cannabis space in pharma, health and wellness and animal health
Access to massive Mexico TAM: US$4.4B category, representing 9 protocols in development
20-year track record of sourcing API, globally
Developed state of the art manufacturing capabilities (cannabis-ready) across a variety of form factors
Established distribution network, strong retail partnerships, access to doctors and researchers already initiating and implementing pharma protocol
Ability to develop proprietary patented products with team of Cannabis experts driving R&D, innovation, and product development
Cannabis Market
Cannabis Market
The cannabis industry is experiencing unprecedented growth globally, this progress in a political level responds essentially to the growing social demand for regulation of the use of medicinal cannabis.
The cannabis plant contains chemical substances that can be useful to treat a wide range of diseases and symptoms.
More and more countries are legalizing marihuana for medicinal use.
Scientists are making clinical and preclinical trials with cannabis and its extracts to treat the symptoms of diseases and other disorders, such as:
- HIV/AIDS
- Multiple sclerosis (MS)
- Inflammation
- Pain seizures
- Drug use disorders
- Mental disorders
The scientific study of chemicals, called cannabinoids, has led to the FDA approval of two cannabinoid containing pills.
Mexico: The Next Significant Market to Come Online
- Largest country on the path to legalization
- Established export infrastructure
- Developed pharma industry low cost market
- Legal and/or legislation in progress
- International sales opportunity
Poised to Dominate Mexico’s Cannabis Market. We are on the inside track with a first mover advantage to tap into a massive market opportunity with significant barriers to entry
20+ years legacy pharma business prepared to launch and take market share in Cannabis space in pharma, health and wellness and animal health
Access to massive Mexico TAM: US$4.4B category, representing 9 protocols in development
20-year track record of sourcing API, globally
Developed state of the art manufacturing capabilities (cannabis-ready) across a variety of form factors
Established distribution network, strong retail partnerships, access to doctors and researchers already initiating and implementing pharma protocol
Ability to develop proprietary patented products with team of Cannabis experts driving R&D, innovation, and product development
All rights reserved. Landsteiner 2024® | COFEPRIS | Do not self-medicate. Consult your physician for additional information.